Friday, 23 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
AIM Vaccine's Serum-Free Rabies Vaccine Accepted for Review by NMPA
CompanyDrug

AIM Vaccine’s Serum-Free Rabies Vaccine Accepted for Review by NMPA

April 8, 2025
SinoMab BioScience's SM17 Shows Promising Results in Phase Ib Atopic Dermatitis Study
CompanyDrug

SinoMab BioScience’s SM17 Shows Promising Results in Phase Ib Atopic Dermatitis Study

April 8, 2025
Luye Pharma's Toludesvenlafaxine Approved for Marketing in Macau
CompanyDrug

Luye Pharma’s Toludesvenlafaxine Approved for Marketing in Macau

April 8, 2025
Shanxi Yanghe Medical Technology Faces Production Halt Over GMP Violation
CompanyDrug

Shanxi Yanghe Medical Technology Faces Production Halt Over GMP Violation

April 8, 2025
Hansoh Pharmaceutical Secures Dual NMPA Approvals for Oncology Pipeline Expansion
CompanyDrug

Hansoh Pharmaceutical Secures Dual NMPA Approvals for Oncology Pipeline Expansion

April 8, 2025
Huadong Medicine's DR30206 Approved for Clinical Trials in Gastrointestinal Tumors
CompanyDrug

Huadong Medicine’s DR30206 Approved for Clinical Trials in Gastrointestinal Tumors

April 8, 2025
Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency
Policy / Regulatory

Beijing Unveils Measures to Accelerate Innovative Drug Development and Regulatory Efficiency

April 8, 2025
Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China
CompanyDeals

Novo Nordisk Partners with Tencent Healthcare for Weight Management Initiative in China

April 8, 2025
Siemens Set to Acquire Dotmatics for $5.1 Billion to Boost Life Sciences R&D
CompanyDeals

Siemens Set to Acquire Dotmatics for $5.1 Billion to Boost Life Sciences R&D

April 8, 2025
Lynmou Medical Secures Series A Funding for Endoscope Expansion
CompanyDeals

Lynmou Medical Secures Series A Funding for Endoscope Expansion

April 8, 2025
Phanes Therapeutics Gains CDE Approval for Peluntamig Phase II Trial in SCLC and NEC
CompanyDrug

Phanes Therapeutics Gains CDE Approval for Peluntamig Phase II Trial in SCLC and NEC

April 8, 2025
Hengrui Pharmaceuticals Licenses SHR7280 to Merck for Assisted Reproduction
CompanyDeals

Hengrui Pharmaceuticals Licenses SHR7280 to Merck for Assisted Reproduction

April 8, 2025
1 2 … 197 198 199 200 201 … 289 290
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up